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Abstract
Purpose: The prevailing controversies on the potential environmental risks of genetically modified organisms
[GMOs] still fuel ongoing discussions among European Union [EU] member states, risk assessors, applicants and
scientists, even several years after the commercial introduction of GMOs. The disagreements mainly derive from the
current risk assessment practice of GMOs and differences in the perceived environmental risks. Against this
background, the aim of this study was to scrutinize the current practice of environmental risk assessment [ERA] of
several GMO applications currently pending for authorisation in the EU.
Methods: We analysed the data presented for three assessment categories of the ERA of genetically modified [GM]
maize applications for cultivation in the European Union: the agronomic evaluations and the assessments of the
effects of GM maize on target organisms and of its potential adverse effects on non-target organisms.
Results: Major shortcomings causing considerable uncertainties related to the risk assessment were identified in all
three categories. In addition, two principles of Directive 2001/18/EC are largely not fulfilled - the consideration of
the receiving environment and the indirect effects, as mediated, e.g. by the application of the complementary
herbicide in the case of herbicide-tolerant GM maize.
Conclusions: We conclude that the current practice of ERA does not comprehensively fulfil the scientific and legal
requirements of Directive 2001/18/EC, and we propose improvements and needs for further guidance and
development of standards. The recommendations address likewise applicants, risk assessors as well as decision
makers.
Background
Authorisation of genetically modified organisms
[GMOs] in Europe is regulated by Directive 2001/18/EU
[1] and Regulation (EC) 1829/2003 [2], respectively. The
objective of Directive 2001/18/EC [1] is to protect
human health and the environment when a GMO is
placed on the market as or in products (Article 1). The
focus is on the preventive action due to the ability of
living organisms to reproduce and the irreversibility of
the release of GMOs in the environment. Thus, the
Directive requires a case-by-case approach to the envir-
onmental risk assessment [ERA] to be carried out prior
to decisions on applications. Annex II of the Directive
defines the general principles of the ERA, the steps, the
methodology and the conclusions to be drawn on the
potential environmental impact from the release or the
placing of GMOs on the market. Annexes III and IV lay
down the information requirements to be included in
applications. When performing the ERA, the applicant
has to consider the ‘risks to human health and the
environment, whether direct or indirect, immediate or
delayed, which the deliberate release or the placing on
the market of GMOs may pose’ (Annex II) [1]. ‘Direct
effects’ are the effects resulting from the GMO itself
without an intermediate chain of events. ‘Indirect effects’
are the effects ‘occurring through a causal chain of
events, through mechanisms such as interactions with
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other organisms, transfer of genetic material, or changes
in use or management of the crop’ (Annex II) [1].
‘Immediate effects’ refer to the effects ‘which are
observed during the period of the release and use of the
GMO’, whilst ‘delayed effects’ are the effects ‘which may
become apparent as a direct or indirect effect either at a
later stage or after termination of the release’ [1].
Similarly, Regulation (EC) 1829/2003 [2] requires ‘a
technical dossier for the application of a GMO supply-
ing the information required by Annexes III and IV of
Directive 2001/18/EC and information and conclusions
about the risk assessment carried out in accordance
with the principles set out in Annex II to Directive
2001/18/EC’ if the scope of the notification covers food
or feed containing or consisting of GMOs (Article 5)
[2]. The information requirements as defined by Annex
III in the Directive are also referred to in the guidance
document of the European Food Safety Authority
[EFSA] [3], although they differ to some extent in struc-
ture and detail.
For many years, the authorisation of genetically modi-
fied plants [GMPs] in the European Union [EU] has
been a controversial issue. Regulation (EC) 1829/2003
[2] introduced a centralised procedure of authorisation
by the European Commission, which includes the con-
sultation of the European Member States [MS] and a
scientific evaluation conducted by EFSA. If a GMO
application encompasses cultivation, EFSA nominates a
MS to conduct an initial appraisal of the ERA submitted
by the applicant. On the basis of this appraisal and com-
plemented with input from MS, EFSA carries out a
scientific evaluation and issues an opinion. Based on this
opinion, the European Commission drafts a decision to
be voted on by MS. Despite the new legislation [1,2,4]
and efforts to strengthen risk assessment guidance and
to promote exchange among the scientific experts of the
EFSA and European MS, no qualified majorities for
decisions on import and processing or cultivation of
GMPs could be reached so far. With the exception of
genetically modified [GM] carnations, all final decisions
have been taken by the European Commission
unilaterally.
Except for a GM potato in 2010, no GM crops have
been approved for cultivation since 1998. Instead, sev-
eral import and cultivation bans have been enacted by
different European MS. For instance, since 1999, the
cultivation of Bacillus thuringiensis [Bt] maize MON810
was banned in Austria, France, Hungary, Luxemburg,
Greece and Germany. Since 2009, at the political level,
discussions are underway to shift the responsibility for
final approval of the cultivation of GM crops to the
national level of the individual MS [5].
The difficulties in decision making at the EU level
have to be contextualized in light of the controversies
among risk assessors, decision makers and scientists in
the EU MS regarding the quality and quantity of the
data submitted for the legally required ERA of GMPs.
On a scientific level, controversies arose on the chosen
methodology of the ERA, the tested endpoints, the dura-
tion of tests and, last but not least, the chosen test
organisms [6-9].
The ‘centralisation’ of the authorisation procedure and
the continuously positive opinions by EFSA considering
the ERAs of the applications as sufficient led to a con-
siderable dispute among MS on the presumed safety of
GMPs. It has also been criticised by EU MS that the
quality of the submitted data varies considerably, and
improvements of the ERA based on common standards
are being demanded [10-13]. These controversies stress
the need for further harmonisation of practices and
methods of assessing the environmental risks of GMPs,
in particular regarding the impact on non-target organ-
isms [NTOs], potential long-term effects and indirect
effects resulting from potential changes in agricultural
management techniques.
Against this background, the Environment Agency
Austria was commissioned by the German Federal
Agency for Nature Conservation to carry out a study
with the aim of evaluating the current practice of the
ERA of GMPs in the EU, describing the compliance
with legal and scientific requirements, identifying possi-
ble shortcomings and proposing improvements of the
data basis and the ERA process where needed [14]. In
this article, the most important findings regarding the
evaluation of GM maize applications are presented.
More details for GM maize and the results for other
GM crops, like herbicide-tolerant [HT] oilseed rape and
GM potato with altered starch composition, can be
found in the full report [14].
Materials and methods
Selection of material for analysis
Seven applications of GM maize including cultivation in
their scope, which have been submitted under the rele-
vant EU legislation [1,2] at that time, were selected for
this analysis. The selected applications of GMPs com-
prise traits representative for GMPs of interest for the
European market, insect resistance and herbicide toler-
ance (Table 1). The documents of the original applica-
tion as well as any additional information submitted by
the applicants before 31 December 2007 were accounted
for. The selection includes both single-trait events (e.g.
maize MON810) and stacked varieties with different
combined events (e.g. maize NK603 × MON810).
The aim of the study was to evaluate the data basis
put forward by applicants for the ERA and its implica-
tions for conducting an ERA. This data basis reflects the
information available for the Competent Authorities
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[CAs] of Member States when performing their risk
assessment. We point out that the intention of this ana-
lysis was not to draw overall conclusions on the poten-
tial environmental risks of the GMPs linked with the
applications. For this reason and because EFSA issues
its opinions after the MS, we decided not to take the
EFSA’s opinions of the applications reviewed into
account. Thus, the analysis exclusively focused on the
ERA and the respective data submitted by the applicants
in support of their ERA. The data presented for the
assessment of effects on human health were omitted
from the analysis due to the lack of direct relevance for
environmental risks.
Rationale and analysis of applications
The procedure of the ERA, including all necessary steps
from hazard identification to the overall risk characteri-
sation, is laid down in Annex II of EU Directive 2001/
18/EC and the supplementing guidance notes [15].
Moreover, in its Annexes, in particular Annex II.D.2
and Annex III.B, EU Directive 2001/18/EC specifies
information requirements which may be necessary to
carry out the ERA. Similarly, these information points
are required to be included in applications according to
Regulation (EU) 1829/2003. In addition, the EFSA gui-
dance document [3] provides specific areas of risk which
have to be addressed during the ERA. It is the quality of
these information elements which was of main concern
in the study commissioned by the German Federal
Agency for Nature Conservation [14], whose purpose
was to critically analyse the data generation by the appli-
cant in order to perform an ERA and, thereby, the infor-
mation basis on which decisions have to be made by
CAs rather than the methodology of the ERA itself.
Consequently, this manuscript does not elaborate on the
general methodology of the ERA, its components and
underlying concepts, but presents an analysis of the data
on which the ERA, the core activity of risk analysis, is
based upon.
As the information elements slightly differ in structure
and detail between EU Directive 2001/18/EC and the
EFSA guidance document [3], we combined them into
ten assessment categories: molecular characterisation,
expression, agronomics, composition, dissemination and
related processes, target organisms, non-target organ-
isms, biogeochemical cycles, change in land use and cul-
tivation technique, and risk management including
monitoring [14]. Among the ten categories studied,
three selected ones are presented in this article: (1)
assessment of the agronomic characteristics of the GMP,
(2) assessment of effects on and mediated by target
organisms [TOs] and (3) assessment of interactions of
the GMP with NTOs.
The analysis of each assessment category followed a
common approach. In principle, the analysis focused on
studies provided by and carried out on behalf of the
applicants. Most of these information are not published
peer-reviewed. If the applicant cites or refers to such
studies, in a first step, their availability and documenta-
tion within the applications was checked. In a second
step, these studies were assessed to comply with good
scientific practice, including appropriate methodology,
experimental design, and statistical analyses and report-
ing, as well as with criteria laid down in the EFSA gui-
dance document [3]. In accordance with the case-by-
case approach outlined in Directive 2001/18/EC (Pream-
ble, points 18 and 19), we considered data on the
respective GMP (i.e. the specific transformation event)
mandatory for the assessment and thus focused on the
data sets specifically generated and presented for the
GMP in question. Consequently, only studies conducted
with the GMP or with the relevant proteins were further
analysed regarding the following aspects:
(1) Agronomic characteristics of the GMP
Number of field locations; number of years and repre-
sentativeness of the selected locations with regard to the
intended market release (in all cases the entire EU);
characterisation of individual locations; choice of
Table 1 Overview of the applications selected for the study (status: December 2007)
GMP Relevant legislation Scope Application number GM traits
Maize MON810 D90a, b Seed (CU, P) C/F/95/12/02 IR
Maize Bt11 D01b, c FO, FE, IP, CU C/F/96/05/10 IR, HT
Maize 1507 D01b CU, I, Pe C/ES/01/01 IR, HT
Maize NK603 Rb FO, FE, I, P, CU EFSA/GMO/NL/2005/22 HT
Maize 59122 Rd FO, FE, I, P, CU EFSA/GMO/NL/2005/23 IR, HT
Maize 1507 × NK603 Rd FO, FE, I, P, CU EFSA/GMO/UK/2005/17 IR, HT
Maize NK603 × MON810 Rd CU EFSA/GMO/NL/2005/26 IR, HT
D90, Directive 90/220EEC; D01, Directive 2001/18/EC; R, Regulation (EC) No. 1829/2003; FO, food use; FE, feed use; I, import; P, processing; IP, industrial processing
and uses; CU, cultivation; Seed, seed production, HT, herbicide tolerance; IR, insect resistance.
aApplication for renewal for authorisation submitted; bscientific opinion issued by EFSA; csubmitted under Directive 90/220/EEC and transferred to Directive 2001/
18/EC; dunder scientific review by EFSA; eexcluding food uses.
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comparators (controls); use of appropriate pesticide
management in trials with HT GMPs; and relevance of
estimated agronomic parameters. The analysis of field
data focused on field trials conducted in Europe as these
are considered to have the highest relevance if a GMP is
to be cultivated in the EU
(2) Effects on and mediated by TOs
Effectiveness of control; occurrence of secondary pests;
effects due to changes in food/prey availability; and
resistance development.
(3) Interactions of the GMP with NTOs
Exposure assessment; test strategy and selection of test
organism (e.g. assessment of relevant functional groups);
toxicological endpoints; multi-trophic effects; and effects
on species of conservation concern. In this category,
laboratory studies using the introduced protein (e.g. Cry
protein), or in some cases parts of the GMP (e.g. pol-
len), were distinguished from whole-plant studies under
containment and whole-plant studies in the field. Addi-
tionally, and only for this category, the published litera-
tures cited in the applications as supporting evidence
were analysed for their relevance (e.g. type of test sub-
stance or GMP used) and their completeness. Under
completeness, we checked whether the citations com-
prised all relevant studies at the time when the applica-
tion was submitted by the applicant and, thus, whether
the state of scientific knowledge was represented.
Results
Analysis of the assessment of agronomic characteristics
of the GMP
Data for the assessment of the agronomic performance
of the GMP were in all cases generated by conducting
field trials at different locations either in one country or
in different countries or even continents. Generally, no
rationale or criteria were given for the selection of the
field sites. For GM maize MON810 and NK603 ×
MON810, no agronomic data obtained under European
conditions were presented (Table 2).
Information on field trial locations was generally
restricted to stating the name of the location and the
country. Climatic data were presented in the applica-
tions of GM maize 1507, 59122 and 1507 × NK603; for
maize 59122 and maize 1507 × NK603, information on
the soil type at a specific location and a map of the loca-
tion were also presented (see [14]).
In a given year, field trials were conducted in one (1995;
maize Bt11; 2002: maize 1507; 2000-2002: maize NK603;
2003: maize 59122) or two (2004: maize 59122; 2003:
maize 1507 × NK603) or three (2000: maize 1507) Eur-
opean countries (Table 2). Except for GM maize 59122 in
Bulgaria, none of the field trials was carried out for more
than two consecutive growing seasons at a given location.
In 60% of genetically modified herbicide-tolerant
(GMHT) maize applications with European field trials,
the agronomic performance was tested in the absence of
the corresponding broad-spectrum herbicides. For GM
maize 1507 and 59122, the respective herbicide treat-
ments were included (Table 2) in the field trial design.
However, for GM maize 1507, the potential differences
between the herbicide-treated GM maize and the
untreated controls were not statistically evaluated in one
year (2000), and no herbicide treatment was included in
the other year of field trials (2002). For GM maize
59122, agronomic parameters were assessed in non-trea-
ted GMPs in all years and at all sites.
The assessment of the agronomic performance of the
GMP included plant growth and development, plant
morphology, plant health and yield using a broad range
of different parameters. Both, quantitative (e.g. ‘yield’)
Table 2 Overview of non-European and European field trials for the collection of agronomic data for GMPs
GMP Years: non-European countries Years: European countries/no. of locations Herbicide applied
(European trials only)
Maize MON810 - - -
Maize Bt11 - 1995: FR/- glu-
Maize 1507 - 2000: FR+IT+BG/3+2+1 glu+/glu-a
2002: ES/3 glu-
Maize NK603 1999: US 2000-2001: DE/4 gly-
2002: FR/4 gly-
Maize 59122 2002/2003: CL 2003: BG/3 glu+/glu-b
2003: US, CA 2004: BG+ES/3+3
Maize 1507 × NK603 - 2003: BG+ES/2+3 gly+ fb glu+
Maize NK603 × MON810 2002: US - -
Two-letter country codes refer to ISO 3166-1 alpha-2 codes (IT, Italy; ES, Spain; FR, France; BG, Bulgaria; DE, Germany; CA, Canada; CL, Chile; US, United States). ‘-’,
no data/information provided in the application; glu+, treatment with glufosinate; glu-, no treatment with glufosinate; gly+, treatment with glyphosate; gly-, no
treatment with glyphosate; fb, followed by.
aNo statistics applied; bagronomic parameters were assessed in non-treated plants only.
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and qualitative (e.g. ‘leaf colour or shape’) parameters,
were assessed by the applicants (see [14]). The measured
parameters were not consistent across all GM maize
applications.
Insect damage of the GMP was evaluated in 29% of
GM maize applications with field trials in Europe (Table
3). No evaluation of insect damage under European field
conditions was carried out for maize events MON810
and NK603 × MON810. In the case of maize Bt11,
assessment of insect damage in one European country
was stated, but no data were presented in the application.
The infestation rates of pests were evaluated by visual
observation and a qualitative rating on a 1 to 6 or a 1 to
9 scale. In the applications of GM maize 1507 and
NK603, additionally, quantitative methods were used,
such as assessing the length of the insect tunnels in the
maize stalks or ears (Table 3).
For insect-resistant [IR] maize applications with field
trials in Europe, the pest species assessed in the insect
damage recording were specified only in the case of maize
1507, although not in all years. For this IR maize and also
maize NK603, although the latter conferring herbicide tol-
erance only, the infestation rate specifically caused by the
European corn borer (Ostrinia nubilalis) was evaluated. In
these two applications, also the Mediterranean corn borer
or pink borer (Sesamia sp.) was evaluated, but also not at
all sites. In no case was reference made to the pest insect
pressure of the respective year and location. With the
exception of maize 1507, it was never indicated whether
the background infestation levels of the TOs in the control
plants were sufficient to demonstrate a relevant level of
control by the GMP.
Analysis of the assessment of effects on and mediated by
target organisms
In applications of HT maize, no TO (i.e. target weeds)
was identified. TOs (i.e. target pest insects), however,
were addressed in applications of IR maize. In applica-
tions of IR maize expressing the Cry1Ab toxin (maize
MON810, maize Bt11, maize NK603 × MON810), O.
nubilalis and Sesamia spp. were indicated as TOs. The
applicant of Bt11 maize listed also other lepidopteran
maize pests occurring in the UK, such as Acronicta
rumicis, Agrotis spp. and Autographa gamma, as TOs.
For maize expressing the Cry1F toxin (maize 1507,
maize 1507 × NK603), O. nubilalis and Sesamia spp.
were listed as TOs. For maize 59122 expressing a binary
toxin (Cry34Ab1/Cry35Ab1), the Western corn root-
worm (Diabrotica virgifera virgifera) was indicated as
the sole TO of this GMP in the EU.
In 67% of IR maize applications, data on the specificity
of the respective Cry proteins to TOs were provided
(Table 4). However, in these cases, the applicant provided
data produced to demonstrate the equivalence of the
Table 3 Insect damage evaluated in European field trials for the assessment of agronomic traits of the GMP
GMP European Field trial
(year/country)
Parameter assessed Method Insect pests assessed
Maize MON810 - - - -
Maize Bt11 1995/FRa - - -
Maize 1507 2000/FR, IT, BG Infestation 1-9 scale, v. e. -
2002/ES Infestation 1-9 scale, v. e. -
Insect tunnels in stalks Insect tunnelling length (cm) O. nubilalis, Sesamia sp. (2 of 3
sites)b








2002/FR Abundance of larvaeb Larvae per stalk/ear O. nubilalis (4 sites)
Sesamia sp. (3 sites)
Borer tunnelsc Length of borer tunnelling in
stalk/ear
% damaged earsc
Maize 59122 2003/BG, 2004/ES, BG Infestation 1-9 scale, v. e. -
Maize 1507 × NK603 2003/ES, BG Infestation 1-9 scale, v. e. -
Maize NK603 ×
MON810
- - - -
’-’, no data provided; v.e., visual estimation; class., classification.
aEvaluated but no data provided; bfor each pest species; cfor both pest species.
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plant-expressed proteins to bacteria-expressed proteins,
for instance by determining bioactivity. Insect bioassays on
pest species were used to conclude on the bioactivity. Data
from bioassays using the actual TOs and the respective
GM maize plant material for which approval was sought
were not provided, with the exception of maize 1507.
However, we consider the efficacy data for maize 1507 as
not scientifically robust due to the fact that the demon-
stration of the capability of 1507 maize to control TOs
rested on a study presenting two mortality values from a
single, non-replicated study at one location in one year in
addition to one study, which did not fulfil minimal scienti-
fic requirements in terms of sample size, replication and
statistical analysis. Studies showing reliable and sustainable
control of Sesamia nonagrioides have not been presented
by the applicant of 1507 maize, and robust data on the
degree of mortality related to different growth stages and
tissues of Cry1F maize were not presented (see [14]).
The applications of the stacked events contained no
studies with the GMPs in question and cited the studies
submitted for the respective single-event IR maize appli-
cation described above. The potential development of
resistance of TOs was taken into account in all applica-
tions of IR GMPs. In each case, insect resistance man-
agement plans were included for O. nubilalis (GM
maize expressing the Cry1Ab or Cry1F toxins) and for
Diabrotica spp. (GM maize 59122). No resistance man-
agement plan was provided or discussed for Sesamia
spp. in the Mediterranean region or for any other listed
target insect organism. For HT GMPs, potential adverse
environmental effects resulting from the development of
resistant weeds were not considered.
Analysis of the assessment of interactions of the GMP
with non-target organisms
All applicants referred to studies assessing the exposure
and/or effects of the respective GMP on NTOs.
However, the number of studies and their quality varied
significantly among the applications (Table 5). In none
of the GM maize applications was a specific evaluation
of the different exposure pathways of different NTOs in
different environmental media (e.g. vegetation, soil and
water) conducted. In 43% of the applications, the expo-
sure of some organisms or groups of organisms to the
GMP was discussed in the ERA (Table 5). In the appli-
cation of maize Bt11, published studies describing the
exposure of Monarch butterflies to B. thuringiensis
maize in the USA were cited, and the applicant referred
to published and unpublished studies on the effects of
the Cry1Ab toxin on Lepidoptera and non-lepidopteran
NTOs. No specific exposure values for individual spe-
cies, regardless whether in Europe or elsewhere, were
calculated or assessed in any detail for maize Bt11.
In the application of maize 1507, exposure was evalu-
ated for non-target Lepidoptera by estimating the pre-
dicted environmental concentration based on pollen
expression levels. The sensitivity data (LD50) were calcu-
lated from toxicological studies of 16 lepidopteran spe-
cies which, with the exception of the Monarch butterfly,
were all pest species [16]. For maize 59122, the B. thur-
ingiensis toxin concentration in different plant tissues
and organisms was calculated and a ‘formal’ exposure
assessment according to the US EPA Guidelines for the
ERA was carried out.
The effects of the toxin expressed in the GMPs on
NTOs were assessed at different levels of containment
(laboratory, greenhouse or field). In 100% of the applica-
tions, the effects of B. thuringiensis proteins on NTOs
were evaluated in laboratory studies using a standard set
of test species representing a typical toxicological testing
regime, e.g. as used for pesticide testing. Most testing
was carried out using honeybees, earthworms, green
lacewings, parasitic hymenoptera and ladybird beetles
(see [14]). Generally, the isolated bacteria-expressed
Table 4 Studies evaluating the efficacy of the GMP in IR GM maize applications
GMP Cry protein expressed in GMP Test substance used in ERA Pest species evaluated in ERA
Maize MON810 Cry1Ab - -
Maize Bt11 Cry1Ab Plant and bacterial proteins ECB, CEW
Maize 1507 Cry1F 1507 maize plants ECB, MCB
Cry1F Plant and bacterial proteins ECB, CEW, TBW, FAW, BCW
Cry1F 1507 maize plants MCB
Maize 59122 Cry34Ab1/Cry35Ab1 Bacterial proteins SCR
Cry34Ab1/Cry35Ab1 Bacterial proteins CEW, ECB, BCW SCR, WCR, NCR, CLA
Cry34Ab1/Cry35Ab1 Bacterial proteins CEW, ECB, NCR, WCR, CBW, CLA
Maize 1507 × NK603 Cry1F See maize 1507 See maize 1507
Maize NK603 × MON810 Cry1Ab - -
’-’, no specific data provided by the applicant; ECB, European corn borer (Ostrinia nubilalis); CEW, corn earworm (Helicoverpa zea); MCB, Mediterranean corn borer
(Sesamia nonagrioides); TBW, tobacco budworm (Heliothis virescens); BCW, black cutworm (Agrotis ipsilon); FAW, fall armyworm (Spodoptera frugiperda); SCR,
Southern corn rootworm (Diabrotica undecimpunctata howardi); WCR, Western corn rootworm (Diabrotica v. virgifera); NCR, Northern corn rootworm (Diabrotica
barberi); CLA, corn leaf aphid (Rhopalosiphum maidis); CBW, cotton boll weevil (Anthonomus grandis).
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proteins were fed to the test organisms. Additionally,
pollen (e.g. ladybird beetles, honeybees, daphnids); pro-
tein suspensions (honeybees, adult ladybirds and parasi-
tic hymenoptera); moth eggs coated with bacteria-
derived protein solutions (green lacewings); or soils
amended with bacteria-produced proteins (earthworms,
springtails) were used. The same laboratory toxicity
tests were submitted in different applications of different
B. thuringiensis maize expressing the same class of tox-
ins (e.g. Cry 1Ab) without taking into account possible
event-specific differences. The measured parameters
related mostly to mortality and, therefore, acute toxicity.
The endpoints used were no-observed-effect-concentra-
tion [NOEC], LC50 or unspecified ‘signs of toxicity’.
Depending on the species assessed, sublethal parameters
were measured in 0% (parasitic hymenoptera, fish), 20%
(bees), 25% (pest Lepidoptera), 33.3% (daphnids, green
lacewing larvae), 40% (earthworms, coccinellids), 50%
(carabids, aphids), 80% (collembola) and 100% (mam-
mals, birds and flower bugs) of the laboratory studies
with NTOs presented in the applications [14].
Only data on NK603, a GMHT maize, were generated
in the semi-controlled greenhouse experiments. None of
the IR maize was equally evaluated under greenhouse
conditions (see [14]). In 57% of the applications, the
GMP was assessed in field studies for potential non-tar-
get effects under European conditions (Tables 5 and 6).
The plots used in these field studies were generally
small or contained only a few plants (see [14]). Sampling
of NTOs was either done using different types of traps
(pitfall or sticky traps, beating of plants) or by visual
inspection of the plants. Either the abundance of the
organisms was recorded or a simple inventory list of
species compiled.
Tritrophic studies were provided in two (29%) of the
applications (GM maize lines 59122 and NK603). How-
ever, the study provided for GM maize 59122 lacked a
verification of the toxin uptake by the prey and the nat-
ural enemy species, respectively. Species of conservation
concern or of aesthetical and cultural value were consid-
ered in 57% of the applications (Table 5). In all these
cases, the Monarch butterfly (Danaus plexippus) was
considered. For maize Bt11, the applicant additionally
cited Lepidoptera listed in Annex IV of the Habitats
Directive 92/43/EEC without providing any toxicity data
or detailed risk assessment.
Potential secondary pests, i.e. pest species replacing
the target organism and being largely insensitive to the











Species of conservation concern/aesthetical/
cultural value
Maize MON810 - Y - Y - -
Maize Bt11 Y Y - Y - - (M, O)e
Maize 1507 Y Ya - Y - Y (M)
Maize NK603 - Y Y - Y -
Maize 59122 Y Y - Y Yd Y (M)
Maize 1507 ×
NK603
- Y, Nb - Y - -
Maize NK603 ×
MON810
- Y, Nc - - - - (M)
Only field studies with the respective GMP were considered.
Lab studies, with isolated proteins/parts of the GMP; greenhouse studies and field studies, with whole plants; Y, study conducted by the applicant or by order of
the applicant; N, reference to assessment in other applications;’-’, no data presented or applicant referred only to the published literature; M, Monarch butterfly;
O, other.
aThree of the nine studies cited are missing in the application; breference to a single-event application of maize 1507; creference to single-event applications of
maize MON810 and maize NK603; dstudy not attached to the application; ereference to published studies, no toxicological studies submitted by the applicant.
Table 6 Studies assessing the adverse effects of GMPs on NTOs under field conditions
GMP US: Locations (years) EU: Locations/country (years)
Maize MON810 2 (1993); 2 (1994); 3 (1995) 2/FR (1995)
Maize Bt11 4 (1997-1998), 2 (1998-19999), 4 (1998-1999), 2 (2000-2001) -
Maize 1507 1 (1999) 2/ES (2002); 1/FR (2000)
Maize NK603 - -
Maize 59122 2 (2001, 2002) 1/ES (2006); 1/HU (2006); 2/ES (2005)
Maize 1507 × NK603 - 1/ES (2005)
Maize NK603 × MON810 - -
Only field studies with the respective GMP were considered.
’-’, no study submitted
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respective toxin, were not considered in any of the
applications. For maize Bt11, secondary infestations of
maize by pathogens such as Fusarium sp. were dis-
cussed. The applicants of the two stacked event maize
applications referred to the risk assessments submitted
in the single-event applications. As for TOs, no further
tests with NTOs and the stacked GMP event or the
combination of the bacteria-derived toxins expressed in
the stack were conducted.
Of the GM maize applications, 57% contained studies
carried out by the applicant with the respective GMP
under field conditions in Europe (Table 6). European
studies were conducted in one or two countries at one
or two locations per country. In two cases, field studies
were mentioned, but data of the respective studies were
not shown (maize NK603 and NK603 × MON810).
Additionally, applicants referred to published field stu-
dies on the NTO effects of B. thuringiensis crops. How-
ever, the respective GMP used in the literature was
generally not indicated when the applicant cited pub-
lished studies for the discussion of the potential adverse
effects of the GMP on NTOs. Applicants also referred
to studies in which not the respective GMP that was the
subject of the requested approval was used. For exam-
ple, for Bt11 maize, the applicant presented a summary
report of various surveys of NTOs in B. thuringiensis
maize fields. This report was not specifically compiled
for Bt11 but for the registration of B. thuringiensis corn
by US authorities and consequently contained studies
with different B. thuringiensis maize events. Five of the
16 studies were conducted with Bt11 maize. From the
total of 16 studies, five were conducted in Europe, how-
ever none of these with maize Bt11. Concerning maize
NK603, seven field studies were cited, but six of these
dealt with other GM crop species such as HT soybean
or HT wheat. The studies cited for stacked event maize
applications generally dealt with the single-event GMPs.
Discussion
From our analyses of seven GM maize applications, we
conclude that the submitted data for ERA are incom-
plete and many crucial aspects regarding ecology and
biostatistics are not addressed. Interactions between the
GMP and its receiving environments are not sufficiently
taken into consideration, and only a few field trials were
carried out in Europe. Furthermore, in the field trials
conducted in Europe, few aspects relevant to the ERA
were included. The field assessments focussed mainly on
agronomic rather than on ecological parameters. A
range of consequences for the different components of
the ERA result from these shortcomings. The most
important ones will be discussed in the following
sections.
Agronomic evaluations of the GMPs lack scientific depth
and standardized protocols
The methods and parameters used for the evaluation of
the agronomic characteristics of the GMPs varied con-
siderably between the applications. We propose to use
standardized parameters and/or methods for the assess-
ment of any potential agronomic differences between
the GM maize and its non-GM control. This is particu-
larly relevant for the assessment of insect damage. The
assessment parameters ‘difference to other insects’ or
‘infestation’, as employed in many applications, cannot
be considered as sufficient for the demonstration of the
efficacy of the GMP regarding different insect pests. The
assessed insect pest species were often not specified, and
rarely quantitative assessments with the respective GMP
were made. In addition, some of the GM maize applica-
tions entirely lacked evaluations of pest susceptibility
under European conditions.
A standardized methodology to assess potential differ-
ences between the GMP and the control plant in the
susceptibility to common and locally important pest
species is urgently needed for applications of GM maize
with IR traits. Existing methods for the evaluation of
pest infestation applied in the evaluation of plant vari-
eties or the authorisation of plant protection products
may also be helpful for reporting and evaluating relevant
pests of GMPs [17-20]. For GMPs, such methods should
be specifically adapted or developed to give applicants a
clear guidance.
Definition of target organisms not consistent with insect
resistance management plans
Regarding the assessment of effects on and mediated by
TOs in the applications, the criteria applied to define
TOs for IR maize remain unclear. For example, in some
cases, all maize-feeding Lepidoptera were considered
TOs. Defining the ‘target’ (and ‘non-target’) pests for a
specific insect-resistant GMP is not trivial. A lepidop-
teran-active B. thuringiensis toxin may work well only
against some out of several lepidopteran pest species that
co-occur on the same crop. For instance, in the USA, the
GM maize varieties expressing the Cry1Ab toxin are
most effective against the European corn borer, but show
lesser insecticidal activity against Spodoptera spp. For
pest control purposes, Spodoptera species are not neces-
sarily ‘targets’ because they are not reliably controlled
below a damage threshold. In our view, TOs should
include only those species that are aimed at being con-
trolled by the respective GMP and for which the efficacy
of the IR crop has been demonstrated. All others should
be classified as non-target pest species.
Therefore, defining the TO for insect-resistant GM
crops should clearly distinguish which lepidopteran
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pests are targeted in combination with the proven effi-
cacy of the GMP for each specific pest. This should
include a delineation of pest species which are not the
primary targets of the GMP but may or are known also
to be affected by the GM trait. The potential of the
development of new major pests and resistance develop-
ment in these species should also be included in the
evaluation. This is necessary for reasons of quality con-
trol, product liability and resistance management.
The identification of the TO(s) for a particular B.
thuringiensis maize event by the applicants was not con-
sistent with the submitted insect resistance management
[IRM] plans for B. thuringiensis crops. These were
exclusively focused on O. nubilalis or D. v. virgifera,
respectively. Other pest species, even if listed as TOs,
such as Sesamia spp., were always left unconsidered in
IRM plans. Especially lepidopteran pest species that may
be affected to a lesser degree by B. thuringiensis toxins
(e.g. Spodoptera spp., Agrotis spp.) [21,22] might develop
resistance fairly quickly. A pest species may be classified
as a ‘non-target pest’ for pest control purposes if it is
not reliably controlled by a particular B. thuringiensis
crop (e.g. Spodoptera spp.), but as a ‘target’ from the
perspective of the insect resistance manager if it is sub-
lethally affected. Hence, a careful definition and justifica-
tion of what is a target and a non-target pest is
important as it has implications for the evaluation of the
interactions of GMPs with NTOs.
Efficacy of the GMP not tested in the field
Efficacy data are a basic element in the assessment of
effects on and mediated by TOs and are as well impor-
tant for the evaluation of the interactions of GMPs with
NTOs. For B. thuringiensis maize expressing the
Cry1Ab or Cry1F protein, only in 20% of the applica-
tions were the target pest species O. nubilalis and Sesa-
mia sp. evaluated in the field (maize 1507; Tables 3 and
4). For maize 59122, no field data were presented pro-
viding evidence that this GM maize is effective in the
field against its coleopteran TO as the insects evaluated
in the field were not indicated in the application (Table
3). Hence, there is no information whether maize 59122
is actually controlling its TO under representative field
conditions in Europe.
In our view, especially with IR crops, the abundance of
not only the target but also non-target pest species
should play an important role in the selection of the
field trial locations considering different GM crop per-
formances due to differential pest infestations and
damaging levels [23-25]. Reporting local target pest den-
sities is also relevant for understanding the baseline
infestation rates in the respective regions. As insect or
weed pressure may vary depending on regional charac-
teristics, local conditions or years, these must be
considered as well. No information was provided in the
applications as to whether the background infestation
levels of the TOs in the control plants were sufficient to
demonstrate the efficacy of the product. This is impor-
tant not only for the quality control of the GMP but
also for balancing the positive desired effect of the treat-
ment (i.e. the TO control) against any potential adverse
environmental effects. If no sufficient control under cer-
tain agronomic conditions can be demonstrated, it is
questionable whether the risk for resistance develop-
ment or of the adverse environmental effects of the
GMP is acceptable.
For example, plant protection products have to be
tested under relevant circumstances where the TO has
been shown to be present at a level causing adverse
effects on an unprotected crop [26]. We suggest gaining
the necessary data in the course of the agronomic eva-
luation of the GMP in relevant and representative loca-
tions of the different receiving environments. This
would allow judging whether or not the GMP is effec-
tive in the envisaged cultivation area and under different
agronomic conditions. Moreover, it would allow the
identification of those production regions with the high-
est pest pressure.
In addition, there is an urgent need for the develop-
ment of standardized procedures that specify which tis-
sues and growth stages of the GMP for each relevant
target pest should be tested. We recommend drafting
respective guidance for IR GMPs. Guidelines for plant
protection products which could be adapted to GMPs
are currently available [19].
Efficacy of the GMP not adequately assessed in the
laboratory
For the assessment of effects on and mediated by TOs,
data on the efficacy and on the basic biological effects
(e.g. mortality, development time, fecundity, etc.) of the
GMPs for all listed target pests are essential. In the
laboratory studies submitted in order to demonstrate
the efficacy of the B. thuringiensis maize events (Table
4), applicants generally tested the bacteria-produced GM
proteins instead of the GM plant. By using only purified
bacterial proteins in optimized diets, any plant/toxin
interactions are excluded, the potential bioactivity of
smaller fragments of B. thuringiensis proteins, e.g. as
found in maize MON810, are overlooked [27], and the
variability in toxin concentrations in planta [28] is not
taken into consideration (see also [7]).
Additionally, these lab studies often included pest spe-
cies that do not occur as pests in Europe (e.g. corn ear-
worm Helicoverpa zea, tobacco budworm Heliothis
virescens, fall armyworm Spodoptera frugiperda). In all
but one case of IR maize expressing a lepidopteran-
active toxin (maize 1507), the applicants failed to
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evaluate the efficacy of the respective proteins to Sesa-
mia sp., a pest common in the south of Europe. Only
67% of the studies for maize expressing a coleopteran-
active toxin (maize 59122) assessed the relevant TO
occurring in Europe, the Western corn rootworm, D. v.
virgifera. For maize MON810 and the corresponding
stacked maize NK603 × MON810, neither studies with
O. nubilalis nor Sesamia spp. were submitted.
Non-consideration of the required broad-spectrum
herbicides and their potential effects on the receiving
environment
TOs were only identified for GMPs with IR traits, but
not for HT traits. As a consequence, the effects of the
GMP-herbicide complex on weeds were not assessed in
any of the applications. However, the effects on weeds
are relevant for the evaluation of the interactions of the
GMP with NTOs. In our view, this reflects one of the
largest deficiencies of the current regulation of HT
GMPs - the exclusion of adverse effects caused by the
altered management and use of the corresponding
broad-spectrum herbicide. To our understanding, this is
in clear contradiction to the requirements of Directive
2001/18/EC recommending an assessment of such indir-
ect effects [1,15].
As a consequence, potential differences in the agro-
nomic or environmental performance of HT maize com-
pared with conventional maize due to the application of
the non-selective herbicide were not addressed in any of
the applications. Data on the performance and efficacy
of the HT GMP under field conditions, for instance an
evaluation of whether GMHT maize would require dif-
ferent herbicide regimes at different times and the con-
sequences of that for the flora and fauna in
agroecosystems, were not submitted. The Farm Scale
Evaluations demonstrated that herbivores, detritivores,
and many of their predators and parasitoids in arable
systems are sensitive to the changes in weed commu-
nities that result from the introduction of new herbicide
regimes [29-32]. Changes in herbicide use are known to
be major driving forces for the intensification affecting
biodiversity in European agricultural landscapes [33-35]
(see also [36] for GMHT crops). In this respect, it has
to be emphasised that weed communities differ signifi-
cantly between continents, countries or even agricultural
regions; hence, any evaluation should consider regional
differences and include plant species growing in the
agricultural environment being of national or regional
conservation concern. However, none of these were
taken into consideration in GMHT maize applications.
Also, resistance development in weeds was left uncon-
sidered within the ERAs. This is in contrast to the GM
maize with IR traits where the resistance development
of TOs has been considered as the most important
(agronomic) risk associated with the cultivation of such
GMPs.
Applicants generally shift the responsibility for the
assessment of potential adverse environmental effects
due to the use of the complementary herbicide to the
authorisation of the herbicide according to Directive 91/
414/EEC [26]. We believe that considerable improve-
ments in the ERA of GMHT crops could be made if
applicants would include some information on the rele-
vant plant protection product to be used with the
GMHT crop submitted according to Directive 91/414/
EEC. This concerns in particular details on the applica-
tion of the plant protection product (rate, timing,
instructions for use, etc.), information on the toxicologi-
cal profile including potential metabolites and data on
the efficacy of the product including resistance risks.
This information should also be available to authorities
under Directive 2001/18/EC when cultivation of a
GMHT crop is envisaged. Otherwise, an assessment of
changed management procedures as recommended in
Directive 2001/18/EC cannot be conducted.
Inadequate approach for the evaluation of interactions of
the GMP with NTOs
The current approach for the assessment of the effects
on NTO applied by the applicants in the applications
reviewed is based on the assumption that a GMP con-
sists of two parts that function in a linear additive fash-
ion: the crop and the novel GM transgene product.
Based on the substantial equivalence concept and when
no statistically relevant compositional changes are
detected, the crop plant as such is declared as safe and,
consequently, only the added transgene product is sub-
ject to testing in the ERA. This approach to the assess-
ment of NTOs is highly disputed in the scientific
community [6,37-40] and fails to comply with the provi-
sions put forward by Directive 2001/18/EC [41,7]. A
consequence of this interpretation of the legal and
scientific requirements for ERA is that clear risk
research hypotheses are often not formulated and tested
for the GMP in question. Hence, the assessment lacks a
well-founded exposure analysis of the GMP in its receiv-
ing environments and meaningful testing of the selected
NTOs from these environments.
In the reviewed applications, only a few applicants car-
ried out an exposure assessment for the respective GMP
(Table 5). The expression values used were either not
based on values derived from European field trials or
were considered in pollen only. For example, the expo-
sure values of maize 59122 were based on the expres-
sion values of one toxin only (Cry34Ab1), although the
pesticidal action of this event depends on the binary
toxins Cry34Ab1/Cry35Ab1 [42]. Once grown commer-
cially, GMPs and GMP transgene products are released
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into the environment and may affect target and NTOs
via different pathways. Even after harvest, the novel pro-
teins will remain in different environmental compart-
ments and affect organisms in different environmental
media or at different trophic levels [43-47]. A well-
founded assessment of potential exposure routes consti-
tutes an important first step in this ERA category. As
for the regulation of plant protection products according
to Directive 91/414/EEC, an analysis of the distribution,
fate, and behaviour of the GMP and parts of the GMP,
together with its transgenic products in the environ-
ment, should be self-evident also for GMPs.
The assessment of the potential effects of the GMP on
NTOs generally comprised few standard laboratory trials
with the isolated bacteria-derived GM protein. Ecotoxi-
city testing of the protein in the absence of the plant
context has been discussed in detail in the full report
[14] and by other authors [7,48,49]. Neither greenhouse
studies nor tritrophic studies were consistently provided,
thus not taking any risks to predators of herbivores
feeding on GMPs into consideration. The few field stu-
dies provided for evaluating potential adverse effects on
NTOs were designed as stand-alone trials with no con-
necting research hypotheses linking laboratory and/or
greenhouse studies with field studies.
Assessment of the potential adverse effects of a GMP
on NTOs is a key element of the ERA. Its quality signif-
icantly depends on the careful identification of poten-
tially exposed NTOs and meaningful testing in different
containment steps. Concepts have been developed on
how to select organisms from the receiving environ-
ments which would not dramatically increase the com-
plexity of the ERA but significantly increase the
scientific rigour and robustness of the results obtained
[41,49]. These concepts comprise an exposure assess-
ment, the selection of functional groups and the classifi-
cation according to their biological functions. The goal
is to focus on species which have an important func-
tional role in a particular cropping system. Impacts on
those species by GMP cultivation would actually result
in an adverse environmental effect. The selected organ-
isms should be used in toxicological tests in the labora-
tory, in the greenhouse or in field studies using the
whole plant [50-52].
Protected species are left unconsidered in the ERA
Species, which are EU-wide, nationally or regionally
endangered and/or protected may be of particular con-
cern if GMPs interfere with their life cycles, habitats,
competitors or food resources. Directive 2001/18/EC
and its guidelines [15] specifically address endangered
species. However, protected species have not been ser-
iously considered in any of the GM maize applications.
This fact, however, has implications for the evaluation
of the interactions of the GMP with NTOs. The only
substitute species mentioned in B. thuringiensis maize
applications is the Monarch butterfly, a species with vir-
tually no relevance for European ecosystems. Even for
maize 59122, which expresses a coleopteran-active pro-
tein, no non-pest, endangered or protected coleopteran
species was considered.
We propose that the selected species for NTO testing
should include key species which allow the evaluation
of possible consequences for species of conservation
concern. This may include species that are biologically
or taxonomically close to endangered or protected spe-
cies for which a thorough exposure assessment is neces-
sary. Due to their vulnerability, highly protected species
should not undergo toxicity testing. The lowest NOEC
for sublethal effects for species ecologically or taxono-
mically close to endangered species should be used in
the risk evaluation. Because the protection goal for
those species differs compared with other NTOs, we
strongly advise using assessment factors different from
those used to assess overall biodiversity effects. The
application of safety margins on the NOEC will then
give an indication of the risk for a particular protected
species.
However, the distribution of endangered or threatened
organisms varies within Europe. For butterflies in Cen-
tral Europe for instance, most threatened species can be
found in eastern France, eastern Austria, the Romanian
Carpathians and eastern Poland [53]. Threatened butter-
fly species as well as their protection status may also
vary depending on the country [54]. So for the selection
of relevant organisms, identification of regional differ-
ences in the protection status of particular species may
be useful. Such species should be particularly considered
during the ERA. Otherwise, ways must be found giving
EU MS the necessary competence to address risks for
endangered and protected species before GMOs are
commercially placed on the market.
Field assessments do not take place in representative
environments
Field trials for agronomic evaluations of the GMPs took
place overseas, in Europe or in both continents. The
number of European countries (ranging from none to
four, mostly two) and the number of locations within a
specific country varied considerably between applica-
tions. Field studies for the assessment of potential effects
on NTOs were more often conducted overseas than in
Europe. Rarely was a specific assessment done in the
same country and at the same location over two conse-
cutive years. The choice of the locations was never justi-
fied by the applicants and the characterisation of the
locations insufficient to judge their representativeness
for European agronomic conditions.
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We conclude that the analysed applications failed to
adequately consider receiving environments relevant in
the EU and therefore do not fulfil the requirements of
Directive 2001/18/EC. The choice of field trial locations,
however, is considered crucial in terms of representa-
tiveness for the agronomic and environmental condi-
tions the GMP is expected to encounter when
commercially cultivated. European environments differ
substantially in biotic and abiotic conditions such as in
the occurrence of TOs (e.g. Sesamia spp.) or NTOs, the
number of generations of TOs (e.g. one or two genera-
tions of O. nubilalis), agricultural practices and agro-
nomic structures (e.g. nitrogen input), cultivation
systems (e.g. low-tillage farming), crop rotation practices
or climatic conditions. These factors will influence
adverse effect scenarios and as such are relevant for all
three assessment categories analysed. Some effects may
become evident only at a regional level. Toxin levels in
the GMP and the infestation rates of target pests are
influenced not only by soil management practices such
as increased nitrogen levels [55-57] but also by other
agricultural management practices such as planting time
and irrigation [25,58]. In this respect, consideration of a
sufficient number of growing seasons is important to
take account of the variability of biotic (e.g. pest pres-
sure) and abiotic (e.g. weather conditions) environmen-
tal factors.
Directive 2001/18/EC [1] and its guidance notes [15]
address the necessity to provide data from different
environments where the GMO will be used; hence, the
potential receiving environment is emphasised (site-by-
site or region-by-region principle) [15]. Since the
authorisation of GMPs so far included all EU countries,
it needs to reflect the full range of biogeographic
regions. Hence, we consider it paramount that any GMP
is tested for its performance, efficacy and potential
adverse environmental effects under various and repre-
sentative environmental conditions in Europe. This view
is also in line with EFSA which requires that ‘multiple
geographical locations representative of the various
environments in which the GMPs will be cultivated
should be covered’ [3]. In our view, the selection of
representative environments in which a particular GMP
will be tested has to be made at the beginning of the
data collection of the ERA taking into account impor-
tant agronomic and environmental factors. During this
selection, considerations should be given to already
existing concepts such as the agro-climatic zones for
plant protection products [19], the European biogeogra-
phical regions mentioned in Directive 92/43/EEC [8]
and the indicative map of European biogeographical
regions developed for assistance to the Natura 2000 pro-
cess [59].
No consideration of trait interactions
Applications of GMPs derived from traditional crossing
of two single-event GMPs (stacked event GMPs) gener-
ally referred to the assessments of the respective paren-
tal, single-event GMPs. Specific testing using the
stacked event GM maize were hardly presented and
potential interactions of transgene products when
expressed in the same plant not addressed by the appli-
cants. However, these interactions are relevant for the
assessment of effects on and mediated by TOs as well as
the evaluation of the interactions of the GMP with
NTOs. Additionally, this approach ignores the legal
requirements of the ‘case-by-case’ approach of Directive
2001/18/EC as well as scientific knowledge. For exam-
ple, B. thuringiensis toxin interactions towards inverte-
brates, when bacteria-expressed but also when expressed
in GMPs (e.g. in case of maize 59122), are well known,
but constantly ignored in the current risk assessment
practice of stacked GMPs (for a review, see [60]).
Stacked GM hybrids also need to undergo individual
testing in the ERA. As for single-event GMPs, this test-
ing should be guided by formulated research hypotheses
and meaningful testing of the stacked GMP in different
levels of containment to comply with the legislative
requirements and the case-by-case principle of Directive
2001/18/EC.
Conclusions
From the evaluation of the data presented for the three
assessment categories in GM maize applications, we
conclude that there is a need for an improvement of the
ERA and its data base if cultivation is envisaged. This
requires a broader ERA concept that includes a thor-
ough exposure analysis and the scientific evaluation of
the whole GMP at different containment levels guided
by testable risk hypotheses. Risk conclusions should be
based on relevant data specifically generated for and
using the GM event in question. Basic information on
the agronomic characteristics and the efficacy of the
GMP as well as its environmental behaviour must be
provided for the ERA. The corresponding herbicide and
its agronomic and environmental consequences also
need to be taken into account. Such an approach would
significantly strengthen the risk conclusions and their
credibility.
Careful attention ought to be paid to the considera-
tion of relevant data obtained from different European
environments. Here, guidance for the selection of repre-
sentative locations for field trials assessing the agro-
nomic and environmental characteristics of the GMP is
urgently needed. There is also a strong need for the
development of standards with respect to the test
designs, methods and parameters to achieve a common
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approach for specific assessments, e.g. the evaluation of
the efficacy of the GMP against its target organism.
Such standards could significantly improve the ERA
without overruling the case-by-case approach.
The aforementioned shortcomings have led to consid-
erable dispute among EU MS, in particular regarding
the data gaps and uncertainties in the ERAs. Neverthe-
less, the presented data were frequently considered suffi-
cient in EFSA GMO panel opinions and the GMP
declared safe with respect to potential effects on the
environment. This apparent discrepancy in the percep-
tion of environmental risks can only be resolved if a
common understanding of how an ERA should be per-
formed and which scientific data should be included will
be achieved. In our view, the addressed suggestions
would significantly improve the quality of the ERAs of
GM maize applications and hence fulfil the require-
ments of Directive 2001/18/EC. EFSA has recently made
an important step forward in updating the guidance on
ERA in collaboration with all stakeholders [61]. This
updated guidance is now under scrutiny by the MS.
End Note
aThe new EFSA guidance document comprises substan-
tial modifications and additional issues (e.g. long-term
effects, field trials, receiving environment). Work on
supplementary guidance (e.g. post-market environmental
monitoring) has not yet been finalized. The work
described in this article has been carried out quite long
before the publication of the new EFSA guidance, but is
still relevant for the discussion process on how to imple-
ment the ERA guidance as a legally binding requirement
by the EC. In this manuscript, some of the discrepancies
between the legal requirements and the data basis used
for the ERA by applicants at the time of the validness of
the ‘old’ EFSA guidance have been presented. No reeva-
luation of these applications in light of the new ESFA
guidance document is envisaged by EFSA. Hopefully, in
the future, the new ESFA guidance, soon in place, will
reduce such discrepancies and contribute to a more
robust data basis for the ERA of GMO applications.
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